DocGo Inc. Cost, Depreciation, Amortization and Depletion
DocGo Inc. (DCGO) reported Cost, Depreciation, Amortization and Depletion of $35.30 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostDepreciationAmortizationAndDepletion · last filed 2023-03-14
- DocGo Inc. cost, depreciation, amortization and depletion for the quarter ending 2022-12-31 was $28.05M.
- DocGo Inc. cost, depreciation, amortization and depletion for the quarter ending 2022-09-30 was $3.01M, a 49.28% increase year-over-year.
- DocGo Inc. cost, depreciation, amortization and depletion for the quarter ending 2021-09-30 was $2.02M.
- DocGo Inc. cost, depreciation, amortization and depletion for fiscal 2022 was $35.30M.
| Period end | Cost, Depreciation, Amortization and Depletion 3 month | Cost, Depreciation, Amortization and Depletion 6 month | Cost, Depreciation, Amortization and Depletion 9 month | Cost, Depreciation, Amortization and Depletion 12 month |
|---|---|---|---|---|
| 2022-12-31 | $28.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $31.06M derived: sum of 2 quarters · filed 2023-03-14 | $35.30M 10-K · filed 2023-03-14 | |
| 2022-09-30 | $3.01M 10-Q · filed 2022-11-08 | $7.25M 10-Q · filed 2022-11-08 | ||
| 2021-09-30 | $2.02M 10-Q · filed 2022-11-08 | $5.51M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |